📰 Practice Guidelines News
Page 5 - Practice Guidelines News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Practice Guidelines. Real-time updates on events, politics, business and more.
March 9, 2024
PRMT5 inhibitors with antiestrogens represents a therapeutic strategy that may overcome resistance to CDK4/6 inhibitors in ER+/RB-deficient breast cancer.
February 28, 2024
Real-Time News, Market Data and Stock Quotes For Junior Mining Stocks.
February 28, 2024
The National Comprehensive Cancer Network recommends ropeginterferon alfa-2b as first-line cytoreductive therapy for polycythemia vera.
February 27, 2024
– Reported OGSIVEO™ net product revenue of $5.4 million in first partial quarter of launch following FDA approval on November 27, 2023 – – Submitted Marketing Authorization Application to...
February 27, 2024
Patients with mismatch repair–deficient, immunohistochemistry-intact colorectal cancer or endometrial cancer benefit from immune checkpoint inhibitors.
February 25, 2024
(BPT) - By Dr. Norman Lepor
February 24, 2024
(BPT) - By Dr. Norman LeporSponsored by Novartis Pharmaceuticals CorporationDr. Lepor was not compensated for his contributions to this article. If you or a loved one has ever had a cardiovascular …
February 24, 2024
(BPT) - By Dr. Norman LeporSponsored by Novartis Pharmaceuticals CorporationDr. Lepor was not compensated for his contributions to this article. If you or a loved one has ever had a cardiovascular …
February 22, 2024
/PRNewswire/ -- Two new measurements have been added to the Health Equity Report Card (HERC)—a tool for improving the quality and equity of cancer care. The...
February 21, 2024
/PRNewswire/ -- Servier, a global leader in oncology focused on delivering meaningful therapeutic progress for the patients it serves, today announced the FDA...